Some studies have confirmed the general risk prediction value of APOB/APOA1 in global populations and the superiority of APOB/APOA1 over HDL or LDL assays alone for early risk identification, which provides strong support for early risk identification in cardiovascular disease [49]. Here, APOA1 is linked to cardiovascular disorder.